CClinicalTrials.gg
CompletedNCT06310135Updated Aug 5, 2025

Filtered Eyewear to Prevent Light-induced Melatonin Suppression - Aim 1

An interventional study of Filtered Eyewear and Unfiltered Eyewear in Sleep Quality, sponsored by Icahn School of Medicine at Mount Sinai. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-05.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to determine the relative effectiveness of monocular and binocular light exposures, with and without selective blue-blocking filtering, on nocturnal melatonin suppression, subjective sleepiness, and visual performance of night shift workers.

Read the detailed description

Over the course of six, 5-hour study nights, 30 participants will be randomized to 6 study conditions, 1) binocular dim-light control unfiltered, (2) monocular dim-light control (one eye occluded), (3) unfiltered binocular, (4) unfiltered monocular (non-dominant eye occluded), (5) filtered binocular (both eyes filtered), (6) filtered monocular (non-dominant eye filtered, the other non-filtered). Saliva samples will be collected every 30 minutes for melatonin levels. Participants will also be asked to provide subjective sleepiness and visual performance will be assessed. Study nights will be separated by one week and each participant will be randomized to one of the six study conditions each night. All participants will see all conditions.

02

Conditions studied

03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's enrollment of 29 is below the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Icahn School of Medicine at Mount Sinai is the lead sponsor of 764 studies on the registry; 181 are open to participants now.

Of its 121 completed or terminated interventional studies of FDA-regulated products, 82 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy

Exclusion criteria

Exclusion Criteria:

  • Bipolar disorder
  • Seasonal depression
  • Diabetes
  • High blood pressure
  • History of cancer
  • Obstructing cataracts
  • Macular degeneration
  • Diabetic retinopathy
  • Glaucoma
  • Use of melatonin supplements
  • Use of beta blockers
  • Use of sleep medications
  • Use of antidepressant medication
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    Unfiltered Monocular

    Unfiltered monocular with the non-dominant eye occluded.

    Device: Unfiltered Eyewear

  • Experimental
    Filtered Binocular

    Filtered binocular with both eyes filtered.

    Device: Filtered Eyewear

  • Experimental
    Filtered Monocular

    Filtered monocular with non-dominant eye filtered, the other non-filtered.

    Device: Filtered Eyewear

  • Experimental
    Unfiltered Binocular

    Unfiltered binocular - neither eye will be filtered.

    Device: Unfiltered Eyewear

  • Placebo comparator
    Dim Light Control

    Dim light with no filters.

    Other: No Filters

Interventions

  • DeviceFiltered Eyewear

    Filtered binocular viewing condition will be produced by eyeglasses frames with orange-tinted blue-blocking filter, eliminating all optical radiation for wavelengths shorter than 540 nm. For the filtered monocular condition, only the lens on the eyeglasses frame on the non-dominant eye will be tinted with the blue-blocking filter.

  • DeviceUnfiltered Eyewear

    For the unfiltered binocular, the subjects will wear transparent eyeglasses frames with no optical power. Unfiltered monocular vision will be produced by an opaque eyepatch occluding the non-dominant eye.

  • OtherNo Filters

    Dim lights with no filters.

06

What researchers measure

Primary outcomes

  1. Melatonin Levels AUC

    Melatonin levels to assess Melatonin Suppression. Saliva samples will be collected every 30 minutes for melatonin levels.

    Time frame: Each night for 6 study nights

Secondary outcomes

  1. Karolinska Sleepiness scale to measure Subjective Sleepiness

    Subjective sleepiness will be measured using the Karolinska Sleepiness scale. This 9-point scale scores range from 1-9, where 1 = "very alert," 3 = "alert," 5 = "neither alert nor sleepy," 7 = "sleepy, but no difficulty remaining awake," and 9 = "very sleepy, fighting sleep, an effort to remain awake." Full scale from 1-9. A higher number indicates greater sleepiness.

    Time frame: Each night for 6 study nights

  2. Numerical Verification Task (NVT)

    The NVT requires participants to compare 2 lists of 20 pairs of 5-digit numerals at 2 contrasts (0.2 and 0.8), and the response time required to complete the task is recorded as the performance measure. A faster response time indicates better visual performance.

    Time frame: Each night for 6 study nights

07

Study locations

1 site
  • Light and Health Research Center
    Menands, New York 12204, United States
08

References and documents

Individual participant data

Plan to share: No — overall results will be shared, not individual results

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06310135
Lead sponsor
Icahn School of Medicine at Mount Sinai
Responsible party
Mariana Figueiro (Professor, Icahn School of Medicine at Mount Sinai) — Principal investigator
First posted
Mar 15, 2024
Start date
May 1, 2024
Primary completion
Oct 31, 2024
Completion
Oct 31, 2024
Last update
Aug 5, 2025

Study contacts

Mariana Figueiro
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion